Advisor Resource Council Biomarin Pharmaceutical Inc Transaction History

Advisor Resource Council

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$76.22 - $98.51 $184,985 - $239,083	2,427 New	2,427 $234,000
Q2 2022 Jul 27, 2022	BUY	$71.48 - $86.85 $173,481 - $210,784	2,427 New	2,427 $201,000
Q1 2022 Apr 20, 2022	SELL	$74.28 - $92.69 $282,264 - $352,222	-3,800 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $272,536 - $347,586	3,800 New	3,800 $336,000
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $293,472 - $335,469	-3,925 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$75.51 - $84.79 $271,609 - $304,989	3,597 Added 1096.65%	3,925 $328,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $24,767 - $27,811	328 New	328 $27,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.